Kala Pharmaceuticals Q3 EPS $(0.68) Misses $(0.67) Estimate, Sales $1.5M Miss $3.64M Estimate

Kala Pharmaceuticals (NASDAQ:KALA) reported quarterly losses of $(0.68) per share which missed the analyst consensus estimate of $(0.67) by 1.49 percent. This is a 7.94 percent decrease over losses of $(0.63) per share

Benzinga · 11/07/2019 13:21

Kala Pharmaceuticals (NASDAQ:KALA) reported quarterly losses of $(0.68) per share which missed the analyst consensus estimate of $(0.67) by 1.49 percent. This is a 7.94 percent decrease over losses of $(0.63) per share from the same period last year. The company reported quarterly sales of $1.5 million which missed the analyst consensus estimate of $3.64 million by 58.79 percent.